Literature DB >> 19743883

Synthesis of structurally simplified analogues of pancratistatin: truncation of the cyclitol ring.

Madhuri Manpadi1, Artem S Kireev, Igor V Magedov, Jeff Altig, Paul Tongwa, Mikhail Yu Antipin, Antonio Evidente, Willem A L van Otterlo, Alexander Kornienko.   

Abstract

Pancratistatin is a phenanthridone-type natural product isolated from several plants of the Amaryllidaceae family. Its potent antiproliferative, antivascular, antiviral, and antiparasitic properties have attracted the attention of synthetic, biological, and medicinal chemists. Pancratistatin's low natural availability and complex structure have steered many of these research projects toward the preparation of its simplified synthetic analogues with useful levels of activity. In this work we have developed synthetic chemistry aimed at the preparation of pancratistatin analogues with a truncated cyclitol portion of the molecule. The described synthetic pathways are based on a highly anti-diastereoselective arylcuprate conjugate addition to gamma-alkoxy-alpha,beta-enoates and syn-selective azidation at the alpha-position of ester enolates. Analogues with the formally cleaved C3-C4 bond, and thus containing an open ring C, as well as a compound containing a truncated lactol moiety in lieu of the cyclitol, were prepared. Several of the analogues exhibited weak antiproliferative activity, with the highest potency observed in the case of the lactol analogue. From these results implications for the design of future pancratistatin analogues are discussed. Furthermore, the synthetic pathways can be used to construct pancratistatin-mimetic libraries, in which the cyclitol moiety is replaced by other cyclic motifs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19743883      PMCID: PMC2791795          DOI: 10.1021/jo901494r

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  36 in total

1.  Studies directed towards the refinement of the pancratistatin cytotoxic pharmacophore.

Authors:  J McNulty; J Mao; R Gibe; R Mo; S Wolf; G R Pettit; D L Herald; M R Boyd
Journal:  Bioorg Med Chem Lett       Date:  2001-01-22       Impact factor: 2.823

2.  Total synthesis and biological evaluation of Amaryllidaceae alkaloids: narciclasine, ent-7-deoxypancratistatin, regioisomer of 7-deoxypancratistatin, 10b-epi-deoxypancratistatin, and truncated derivatives.

Authors:  Tomas Hudlicky; Uwe Rinner; David Gonzalez; Hulya Akgun; Stefan Schilling; Peter Siengalewicz; Theodore A Martinot; George R Pettit
Journal:  J Org Chem       Date:  2002-12-13       Impact factor: 4.354

3.  Stereospecific biocatalytic synthesis of pancratistatin analogues.

Authors:  Anh Nga Phung; Maria Teresa Zannetti; Gregg Whited; Wolf-Dieter Fessner
Journal:  Angew Chem Int Ed Engl       Date:  2003-10-13       Impact factor: 15.336

4.  Synthesis and biological activity of some structural modifications of pancratistatin.

Authors:  Uwe Rinner; Heather L Hillebrenner; David R Adams; Tomas Hudlicky; George R Pettit
Journal:  Bioorg Med Chem Lett       Date:  2004-06-07       Impact factor: 2.823

5.  Antineoplastic agents 453. Synthesis of pancratistatin prodrugs.

Authors:  G R Pettit; B Orr; S Ducki
Journal:  Anticancer Drug Des       Date:  2000-12

6.  Antineoplastic agents. 450. Synthesis of (+)-pancratistatin from (+)-narciclasine as relay(1a).

Authors:  G R Pettit; N Melody; D L Herald
Journal:  J Org Chem       Date:  2001-04-20       Impact factor: 4.354

7.  In vitro activities of two antimitotic compounds, pancratistatin and 7-deoxynarciclasine, against Encephalitozoon intestinalis, a microsporidium causing infections in humans.

Authors:  M Ouarzane-Amara; J F Franetich; D Mazier; G R Pettit; L Meijer; C Doerig; I Desportes-Livage
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

8.  Antiviral (RNA) activity of selected Amaryllidaceae isoquinoline constituents and synthesis of related substances.

Authors:  B Gabrielsen; T P Monath; J W Huggins; D F Kefauver; G R Pettit; G Groszek; M Hollingshead; J J Kirsi; W M Shannon; E M Schubert
Journal:  J Nat Prod       Date:  1992-11       Impact factor: 4.050

9.  Antineoplastic agents 500. Narcistatin.

Authors:  George R Pettit; Noeleen Melody; Michael Simpson; Michael Thompson; Delbert L Herald; John C Knight
Journal:  J Nat Prod       Date:  2003-01       Impact factor: 4.050

10.  Antineoplastic agents. 511. Direct phosphorylation of phenpanstatin and pancratistatin.

Authors:  George R Pettit; Noeleen Melody; Delbert L Herald
Journal:  J Nat Prod       Date:  2004-03       Impact factor: 4.050

View more
  6 in total

1.  Chemoenzymatic synthesis of Amaryllidaceae constituents and biological evaluation of their C-1 analogues. The next generation synthesis of 7-deoxypancratistatin and trans-dihydrolycoricidine.

Authors:  Jonathan Collins; Uwe Rinner; Michael Moser; Tomas Hudlicky; Ion Ghiviriga; Anntherese E Romero; Alexander Kornienko; Dennis Ma; Carly Griffin; Siyaram Pandey
Journal:  J Org Chem       Date:  2010-05-07       Impact factor: 4.354

2.  Synthesis of C-1 homologues of pancratistatin and their preliminary biological evaluation.

Authors:  Sergey Vshyvenko; Jon Scattolon; Tomas Hudlicky; Anntherese E Romero; Alexander Kornienko
Journal:  Bioorg Med Chem Lett       Date:  2011-06-22       Impact factor: 2.823

3.  Unnatural C-1 homologues of pancratistatin - Synthesis and promising biological activities.

Authors:  Sergey Vshyvenko; Jon Scattolon; Tomas Hudlicky; Anntherese E Romero; Alexander Kornienko; Dennis Ma; Ian Tuffley; Siyaram Pandey
Journal:  Can J Chem       Date:  2012-09-19       Impact factor: 1.118

4.  Synthesis and biological evaluation of unnatural derivatives of narciclasine: 7-aza-nornarciclasine and its N-oxide.

Authors:  Sergey Vshyvenko; Mary Rose Reisenauer; Snezna Rogelj; Tomas Hudlicky
Journal:  Bioorg Med Chem Lett       Date:  2014-07-19       Impact factor: 2.823

5.  5,10b-Ethanophenanthridine amaryllidaceae alkaloids inspire the discovery of novel bicyclic ring systems with activity against drug resistant cancer cells.

Authors:  Sean Henry; Ria Kidner; Mary R Reisenauer; Igor V Magedov; Robert Kiss; Véronique Mathieu; Florence Lefranc; Ramesh Dasari; Antonio Evidente; Xiaojie Yu; Xiuye Ma; Alexander Pertsemlidis; Regina Cencic; Jerry Pelletier; David A Cavazos; Andrew J Brenner; Alexander V Aksenov; Snezna Rogelj; Alexander Kornienko; Liliya V Frolova
Journal:  Eur J Med Chem       Date:  2016-05-06       Impact factor: 6.514

6.  Stereoselective synthesis of trans-dihydronarciclasine derivatives containing a 1,4-benzodioxane moiety.

Authors:  Gábor Varró; Balázs Pogrányi; Alajos Grün; András Simon; László Hegedűs; István Kádas
Journal:  Monatsh Chem       Date:  2018-10-26       Impact factor: 1.451

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.